Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

PHASE3CompletedINTERVENTIONAL

Enrollment

900

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Malaria, Falciparum

Interventions

DRUG

chlorproguanil-dapsone-artesunate

DRUG

chlorproguanil-dapsone

Trial Locations (7)

GSK Investigational Site, Ouagadougou

GSK Investigational Site, Kumasi

GSK Investigational Site, Bamako

GSK Investigational Site, Ile-Ife

GSK Investigational Site, Jos

GSK Investigational Site, Lagos

GSK Investigational Site, Maiduguri